Who Owns the World's Seeds and Why It Matters
The transformation of seed from commons to corporate asset is one of the most consequential restructurings of a global industry in recent economic history. It occurred rapidly, driven by specific legal, financial, and technological dynamics, and its consequences are still unfolding. A full analysis requires understanding the acquisition history in detail, the regulatory environment that permitted it, the effects on seed price and farmer choice, and the implications for food system governance at global scale.
The Acquisition Wave: How Consolidation Happened
Seed industry consolidation followed a predictable pattern. Biotechnology companies in the late 1980s and early 1990s recognized that their patented genetic traits — primarily herbicide tolerance and insect resistance — required delivery through adapted seed varieties. A patented trait is useless without a seed variety adapted to specific growing conditions that farmers actually use. Acquiring seed companies with strong regional germplasm libraries was the fastest route to wide deployment of proprietary traits.
Monsanto's acquisition strategy is the clearest example. Beginning in the mid-1990s, Monsanto acquired Holden's Foundation Seeds (1997), DeKalb Genetics (1998), Asgrow (1997), Delta & Pine Land (2007), and dozens of smaller regional seed companies. Each acquisition brought a germplasm library — thousands of inbred lines adapted to specific regions and conditions — that could be converted from publicly accessible genetics into vehicles for proprietary traits. Monsanto paid premium prices for these acquisitions because the germplasm libraries, combined with its trait patents, created market positions that could sustain premium seed pricing indefinitely.
DuPont Pioneer and Syngenta executed similar strategies. By 2010, the six largest seed companies (Monsanto, DuPont, Syngenta, Bayer CropScience, Dow, and BASF) controlled approximately 65% of the global proprietary seed market. Then a second wave of consolidation occurred. Between 2015 and 2018, three mega-mergers restructured the industry again: Dow and DuPont merged to create DowDuPont (later restructured into Corteva for agriculture), ChemChina acquired Syngenta, and Bayer acquired Monsanto. Three of the six major players became two, reducing the number of dominant firms in the global seed market to effectively four.
The merger review processes in the United States and European Union imposed some divestitures as conditions of approval — Bayer divested its seed business to BASF to gain EU approval, for instance. But the divestitures were selective and the core consolidation proceeded. The global commercial seed market emerged from the merger wave substantially more concentrated than it entered it.
Market Concentration Data: What the Numbers Show
The most comprehensive analysis of global seed market concentration, compiled by researchers at ETC Group and corroborated by academic studies, shows that by 2018:
The top four companies controlled approximately 60% of the global commercial seed market by sales value. For specific commodity crops in the United States, the concentration was higher: Corteva and Bayer controlled approximately 65-70% of the U.S. corn seed market. Bayer and Corteva together controlled over 50% of the U.S. soybean seed market. Cotton seed markets in the United States were similarly concentrated.
The commercial seed market, however, does not represent the entire seed supply. Farmer-saved seed — illegal for patented varieties but widely practiced for traditional and open-pollinated varieties — remains significant in many developing country contexts. Public varieties from national agricultural research institutes, though declining, remain important in some markets. The corporate market share figures represent control over the commercial seed sector, which is dominant for commodity crops in the Global North and increasingly penetrating smallholder farming systems in the Global South.
What the numbers obscure is the patent portfolio concentration, which may be more strategically significant than market share. Even when a farmer plants a variety from a smaller company, that variety may contain patented traits licensed from a dominant company — meaning the dominant company captures royalty income from the transaction regardless of which brand name appears on the bag. The trait patent portfolio is the structural foundation of market power; seed brand market share is the visible expression of it.
Seed Prices: The Cost of Concentration
The most direct economic impact of seed industry consolidation on farmers is seed price inflation. Philip Howard at Michigan State University and other agricultural economists have documented systematic seed price increases that exceed input cost inflation in markets dominated by proprietary varieties.
U.S. soybean seed prices provide the clearest data. In 1996, before widespread adoption of Roundup Ready soybeans, the average price of soybean seed was approximately $15-17 per 50-pound unit. By 2012, the average price was approximately $55-60 per unit — a real price increase of roughly 200-250% after adjusting for inflation. The trait fees embedded in soybean seed prices roughly tripled over this period. These increases tracked Monsanto's increasing market dominance and the expiration of competing patents, not input cost increases.
Corn seed showed similar dynamics. Average corn seed prices rose from approximately $80 per bag in 2000 to over $300 per bag by 2015 in some premium product lines. The premium was justified by stacked traits — multiple patented traits combined in a single variety — that provided genuine agronomic benefits in some contexts. But the pricing also reflected market power: farmers with no competitive alternatives for adapted inbred lines with specific trait packages could not negotiate. They paid the list price.
The economic burden of seed price inflation is distributed across the farming population but falls hardest on smaller operations. Large farms can negotiate volume discounts, access credit on better terms, and spread input costs over more acres. Small farms pay higher per-unit prices for seed and cannot spread the cost across large acreages. The economic pressure from seed price inflation is one factor contributing to ongoing farm consolidation in the United States — smaller farms become financially unviable, and their land is absorbed into larger operations that can capture economies of scale on input costs.
The Agrochemical Tie: Seeds, Herbicides, and Bundled Market Power
The vertical integration of seed and agrochemical businesses in the dominant firms creates bundled market power that extends beyond either sector individually. The Roundup Ready system is the model: Monsanto's patented seed varieties were designed to tolerate glyphosate herbicide (Roundup), which Monsanto also sold. Farmers who planted Roundup Ready seed had a strong economic incentive to use Roundup for weed management — it was effective, was safe to apply over the top of the crop, and was sold by the same supplier.
For most of the 1990s and 2000s, Monsanto held both the Roundup Ready patent and the glyphosate patent (the latter expired in 2000, but Roundup brand commanded premium pricing and distribution advantages). The company captured margin on both the seed and the herbicide. When the Roundup Ready patent expired and generic glyphosate became widely available, Monsanto introduced Roundup Ready 2, with an extended patent life. The strategy of using seed-herbicide integration to maintain herbicide revenue beyond patent expiration was explicit.
ChemChina's acquisition of Syngenta and Bayer's acquisition of Monsanto both created companies combining seed and agrochemical portfolios at scale. Corteva similarly maintains integrated seed and crop protection businesses. The bundling is not coincidental — the companies recognize that controlling both the seed and the chemical inputs required by that seed creates a market structure in which competition on either product is difficult without matching integration on the other.
The environmental consequences of bundled seed-herbicide markets include the dramatic expansion of herbicide-tolerant weed species. When an entire farm system is managed with a single herbicide because the planted variety is designed around it, selection pressure for herbicide resistance in weed populations is intense. Glyphosate-resistant "superweeds" — palmer amaranth, waterhemp, giant ragweed — now infest millions of acres of U.S. farmland. The corporate response has been to introduce seed varieties with tolerance to additional herbicides (dicamba, 2,4-D), creating new bundled seed-herbicide markets and new weed resistance selection pressure. The cycle reproduces itself while expanding the agrochemical market.
Global South Dynamics: Expansion Strategies and Resistance
The major seed companies have identified developing country markets — South and Southeast Asia, sub-Saharan Africa, Latin America — as growth frontiers. The U.S. and European commodity crop markets are mature; growth there requires taking market share from competitors. Developing country smallholder farmers who currently use farm-saved seed or public varieties represent potential converts to proprietary seed markets.
The expansion strategy involves several elements. Public-private partnerships with national governments and international development organizations provide legitimacy and distribution infrastructure. Philanthropy — notably the Gates Foundation's agricultural development programs through AGRA (Alliance for a Green Revolution in Africa) — has directed significant resources toward agricultural systems that favor commercial input adoption, including proprietary seed. Regulatory harmonization — pushing developing countries to adopt intellectual property and biosafety frameworks compatible with proprietary seed trade — removes legal barriers to market entry.
The resistance to this expansion has been organized and politically significant. La Via Campesina and allied organizations have consistently challenged both the intellectual property frameworks and the specific corporate expansion strategies. India's Protection of Plant Varieties and Farmers' Rights Act of 2001 explicitly preserved the farmer's right to save, use, sow, resow, exchange, share, or sell farm produce including seed, providing a stronger farmer exemption than most comparable legislation. Several African nations have resisted UPOV 1991 adoption, maintaining farmers' rights provisions in their plant variety protection legislation.
The specific case of Bt cotton in India demonstrates both the expansion dynamic and its limits. Monsanto's Bt cotton varieties, introduced in India in the early 2000s, were widely adopted by cotton farmers seeking protection from bollworm damage. Adoption was rapid and genuine yield benefits followed. But trait fees increased dramatically over the decade following introduction. By 2016, Monsanto's effective control over the Indian Bt cotton market — through licensing agreements with Indian seed companies that contained its Bt trait — gave it pricing power that the Indian government ultimately challenged, imposing price controls on Bt cotton trait fees. Monsanto threatened to exit the Indian market. The dispute illustrated the geopolitical dimension of seed ownership: a corporation's intellectual property in a critical agricultural input could be deployed as leverage against a national government's regulatory authority.
The Public Breeding Alternative and Its Decline
The counterfactual to corporate seed monopoly is publicly funded plant breeding — universities, national research institutes, and international centers (the CGIAR network) maintaining breeding programs that develop improved varieties available without IP restrictions. This system existed and functioned well through much of the twentieth century. The Green Revolution varieties that transformed Asian agriculture were products of public breeding programs at CIMMYT and IRRI, released without plant variety protection.
The public breeding system has declined significantly relative to the corporate system over the past three decades. In the United States, public plant breeding budgets at land-grant universities have been reduced as state funding has tightened and as corporate funding has shifted research priorities toward proprietary research. The number of public plant breeders working on major commodity crops has fallen significantly. In developing countries, structural adjustment-era cuts to agricultural research budgets reduced national research institute capacity. International assistance that previously supported public agricultural research has, in some cases, shifted toward supporting public-private partnerships that include corporate partners.
The consequence is a weakened alternative to corporate seed supply. Farmers who want to access publicly developed varieties have fewer options than they did in 1980. The space for sovereign, farmer-controlled seed systems has narrowed not only because corporate alternatives have expanded but because the public institutions that could maintain that space have contracted.
Rebuilding public plant breeding capacity is a prerequisite for genuine seed sovereignty. So is the maintenance of farmer seed networks and community seed banks that preserve the biological diversity that corporate plant breeding does not prioritize. The question of who owns the world's seeds is not settled. But the direction of the past fifty years has been unambiguous, and reversing it requires deliberate policy choices that treat seed as a commons rather than a commodity.
Comments
Sign in to join the conversation.
Be the first to share how this landed.